Although our study focuses on an HFD-induced type 2 diabetes model, future research with genetically modified mice, like leptin-deficient db/db mice [72], may reinforce the significance of the SUMOylation pathway in DPN onset and progression. This evidence concerns the gene LEP and type 2 diabetes mellitus.